Drug intelligence / Profile preview

Emcur Nagelpilz-Serum

Development stage: Unknown
Lead developer: Serrix
Modality: Small Molecules
Administration: Topical

Overview

Emcur Nagelpilz-Serum is an over-the-counter (OTC) topical treatment developed by Emcur Gesundheitsmittel aus Bad Ems for the management of onychomycosis (nail fungus). The serum is formulated to penetrate the hard keratin of the nail plate to reach the site of infection. Its primary mechanism of action involves altering the microenvironment of the nail, typically by lowering the pH level, which creates an inhospitable environment for the growth and survival of fungal pathogens such as dermatophytes. As a consumer health product, it is marketed for direct application to affected fingernails or toenails to improve nail appearance and prevent the spread of infection.

Brand names: Emcur Nagelpilz-Serum
Other names: Emcur Nail Fungus Serum

Beyond the preview

Go deeper on Emcur Nagelpilz-Serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emcur Nagelpilz-Serum.

Explore the full profile